Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: miraje who wrote (453506)	9/5/2003 5:36:59 PM
From: Lizzie Tudor	Respond to of 769670

I agree the FDA is an outrageous and inefficient beaurocracy. But the thing is, if it is not cost effective to develop some of these drugs, the hard reality is, maybe they shouldn't be developed. I remember in the early 90s we had a biotech stock frenzy and a bunch of companies like Synergen boomed and busted on these drugs to treat this rare blood problem, sepsis. Sepsis is a killer but it is rare and sepsis drugs cost millions to produce. Is this a cost effective way to deal with this? Doesn't seem like it to me. Maybe we should focus our energies on getting mainstream drug costs down, thanks to more efficient processes or who knows. It seems like these expensive sepsis drugs are still going on in.news.yahoo.com